Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
University of Freiburg
Headquarters: Freiburg, Germany
Website: http://www.uni-freiburg.de
Year Founded: 1457
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Jun 2, 2023
Product Development
Epigenome editing companies showcase progress at ASGCT
Modalis accomplishes gene activation, while Tune achieves gene repression, both in non-human primates
BioCentury | Apr 13, 2022
Emerging Company Profile
Versant’s Cimeio debuts with $50M to shield cell therapies with gene editing
Start-up based in Basel, Boston reaches for new cell therapy and transplant applications with cell shielding technology
BioCentury | Aug 8, 2019
Translation in Brief
Lab mice with ‘wild’ microbiomes better reflect clinical data
NIH’s ‘wildling’ mice could be a better animal model for testing drug candidates
BioCentury | Oct 26, 2017
Translation in Brief
Transient nanotargeting
mRNA-loaded nanoparticles transiently modify therapeutic cells simply and safely
BioCentury | Jun 23, 2017
Emerging Company Profile
TRuCs vs. CARs
Why TCR2's TRuCs could beat out CAR T therapies in solid tumors
Items per page:
1 - 10 of 30